tiprankstipranks
Advertisement
Advertisement

CHRO Stock Latest News

Nurix Therapeutics price target raised to $33 from $26 at Baird
The FlyNurix Therapeutics price target raised to $33 from $26 at Baird
3d ago
CHRO
NRIX
Genentech says FDA accepts sBLA for for Lunsumio VELO
PremiumThe Fly
Genentech says FDA accepts sBLA for for Lunsumio VELO
3d ago
CHRO
FDA approves generic of Genentech’s Xofluza tablets
PremiumThe Fly
FDA approves generic of Genentech’s Xofluza tablets
3d ago
CHRO
CMS proposes to lock in lower prices in Medicare drug price negotiation program
PremiumThe Fly
CMS proposes to lock in lower prices in Medicare drug price negotiation program
6d ago
AZN
BMY
Roche reports FDA approval for prostate cancer companion diagnostic
PremiumThe Fly
Roche reports FDA approval for prostate cancer companion diagnostic
8d ago
AZN
CHRO
OraSure announces FDA clearance of Colli-Pee Dx Urine Collection Kit
PremiumThe FlyOraSure announces FDA clearance of Colli-Pee Dx Urine Collection Kit
10d ago
CHRO
OSUR
Genentech granted priority review for Tecentriq Hybreza combination
Premium
The Fly
Genentech granted priority review for Tecentriq Hybreza combination
10d ago
CHRO
Roche announces EU IVDR approval of several Ventana label expansions
Premium
The Fly
Roche announces EU IVDR approval of several Ventana label expansions
10d ago
CHRO
Nurix Therapeutics price target raised to $32 from $30 at Truist
PremiumThe Fly
Nurix Therapeutics price target raised to $32 from $30 at Truist
12d ago
CHRO
NRIX
Nurix Therapeutics price target raised to $45 from $41 at Jefferies
PremiumThe Fly
Nurix Therapeutics price target raised to $45 from $41 at Jefferies
13d ago
CHRO
NRIX
Nurix Therapeutics downgraded to Equal Weight at Wells Fargo after Roche deal
PremiumThe Fly
Nurix Therapeutics downgraded to Equal Weight at Wells Fargo after Roche deal
13d ago
CHRO
NRIX
Video: Marvell, Flex rise after selection for S&P 500
PremiumThe Fly
Video: Marvell, Flex rise after selection for S&P 500
13d ago
CPB
LLY
Nurix Therapeutics teams with Roche to develop, commercialize bexobrutideg
PremiumThe FlyNurix Therapeutics teams with Roche to develop, commercialize bexobrutideg
13d ago
CHRO
NRIX
Acting FDA head vows to block political interference, Endpoint News says
Premium
The Fly
Acting FDA head vows to block political interference, Endpoint News says
16d ago
AZN
BMY
Roche reports developing PCR test for Ebola within six days
Premium
The Fly
Roche reports developing PCR test for Ebola within six days
17d ago
CHRO
Ideaya Biosciences announces IDE892 collaboration with Roche
PremiumThe Fly
Ideaya Biosciences announces IDE892 collaboration with Roche
18d ago
CHRO
IDYA
FDA issues draft guidance to help accelerated cell, gene therapies for patients
PremiumThe Fly
FDA issues draft guidance to help accelerated cell, gene therapies for patients
19d ago
AZN
BMY
Genentech announces FDA acceptance of giredestrant NDA under Priority Review
PremiumThe Fly
Genentech announces FDA acceptance of giredestrant NDA under Priority Review
19d ago
CHRO
Trump Trade: Trump announces expansion of TrumpRx.gov
PremiumThe Fly
Trump Trade: Trump announces expansion of TrumpRx.gov
1M ago
AZN
BMY
Trump to announce ‘dramatic expansion’ of TrumpRx offerings, CNBC says
PremiumThe FlyTrump to announce ‘dramatic expansion’ of TrumpRx offerings, CNBC says
1M ago
AZN
BMY
Davis to become acting director of CDER after Hoeg exit, Bloomberg says
Premium
The Fly
Davis to become acting director of CDER after Hoeg exit, Bloomberg says
1M ago
AZN
BMY
FDA approves Genentech’s Tecentriq for adjuvant muscle-invasive bladder cancer
Premium
The Fly
FDA approves Genentech’s Tecentriq for adjuvant muscle-invasive bladder cancer
1M ago
CHRO
NTRA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >